| Title | A Phase 1b Study to Assess the Safety, Tolerability, and Clinical Activity of BGB-290 in Combination with Temozolomide (TMZ) in Subjects with Locally Advanced or Metastatic Solid Tumors |
|---|---|
| Disease/Condition | Breast Cancer,Gastrointestinal Cancer,Lung Cancer,Prostate Cancer,Solid Tumor,Oncology (Medical/Hematologic),Cancer,Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Sanjay Goel, MD |
| Contact Name | Mohammad Ghalib |
| Contact Email | mhghalib@montefiore.org |
| Protocol Number | 17-06-152Q-01 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Locally Advanced or Metastatic Solid Tumors |
| Adult, Pediatric, Both | Adult |